Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $37.5900 (-6.19%) ($37.5000 - $39.4300) on Fri. Jun. 24, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.67% (three month average) | RSI | 25 | Latest Price | $37.5900(-6.19%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(40%) XBI(35%) XLV(32%) ARKG(29%) IWF(28%) | Factors Impacting SGEN price | SGEN will decline at least -1.335% in a week (0% probabilities). VIXM(-14%) UUP(-7%) TLT(-6%) SHY(-3%) GDXJ(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.335% (StdDev 2.67%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $40.23 | 5 Day Moving Average | $38.85(-3.24%) | 10 Day Moving Average | $38.78(-3.07%) | 20 Day Moving Average | $40.23(-6.56%) | To recent high | -14.1% | To recent low | 14.1% | Market Cap | $6.536b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |